← FDA DRUG APPROVALS

FDA ANDA · ANDA201146

DONEPEZIL HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD

APPLICATION
ANDA201146
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-17
LATEST ACTION
2023-06-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 5MG · TABLET · ORAL
DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

2023-06-07Labeling · Supplement 22 · standardAP
2020-11-13Labeling · Supplement 15 · standardAP
2016-11-08Labeling · Supplement 8 · standardAP
2014-11-06Manufacturing (CMC) · Supplement 3 · unknownAP
2013-11-07Labeling · Supplement 2 · standardAP
2012-08-17Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →